About
Linagliptin/Metformin extended-release is a combination medication designed for convenient once-daily administration to effectively manage type 2 diabetes mellitus. Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, enhances the body's natural ability to lower elevated blood glucose levels. It achieves this by inhibiting the breakdown of incretin hormones, leading to increased glucose-dependent insulin release from the pancreas and decreased glucagon secretion, which helps to regulate blood sugar after meals and overnight.
Metformin, a biguanide, complements linagliptin's action by primarily reducing glucose production by the liver and improving insulin sensitivity in peripheral tissues, thereby enhancing glucose uptake and utilization. The extended-release formulation of metformin allows for a gradual and sustained release of the drug, providing consistent glycemic control throughout the day and often improving gastrointestinal tolerability compared to immediate-release formulations. This combination offers a comprehensive approach to glycemic management, targeting multiple pathways involved in the pathogenesis of type 2 diabetes.
Uses
- Treatment of type 2 diabetes mellitus.
- To improve glycemic control in adults.
- Used as an adjunct to diet and exercise.
- For patients requiring both linagliptin and metformin.
Directions For Use
Take this medication orally, once daily with the evening meal, as directed by your physician. Swallow the extended-release tablet whole; do not crush, cut, or chew.
Benefits
- Offers convenient once-daily dosing.
- Provides sustained blood glucose control.
- Reduces post-meal glucose excursions.
- Improves insulin sensitivity and reduces hepatic glucose output.
- Lower incidence of gastrointestinal side effects compared to immediate-release metformin.
- Low risk of hypoglycemia (as monotherapy).
Side Effects
- Diarrhea
- Nausea
- Abdominal discomfort
- Headache
- Nasopharyngitis
- Hypoglycemia (when combined with sulfonylureas/insulin)
- Lactic acidosis (rare but serious, due to metformin)
- Pancreatitis (rare, due to linagliptin)
- Joint pain (arthralgia)
- Skin reactions (e.g., rash)
- Vitamin B12 deficiency (long-term metformin use)
- Metallic taste
Safety Measures
- Alcohol - Avoid excessive alcohol intake, as it can increase the risk of lactic acidosis (due to metformin) and hypoglycemia.
- Pregnancy - Not recommended during pregnancy. Insulin is generally preferred for glycemic control in pregnant women with diabetes. Consult a doctor.
- Breastfeeding - Avoid use during breastfeeding as both components are excreted in milk and could pose risks to the infant.
- Liver - Use with caution in patients with liver impairment. Metformin is contraindicated in severe hepatic impairment due to increased risk of lactic acidosis.
- Kidney - Contraindicated in severe renal impairment (eGFR <30 mL/min/1.73m²). Dose adjustment is required for moderate impairment.
- Lung - Use with caution in conditions causing hypoxia (e.g., severe lung disease, acute heart failure) as these can increase the risk of lactic acidosis.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!